Bevacizumab combined with chemotherapy for ovarian cancer: an updated systematic review and meta-analysis of randomized controlled trials. [electronic resource]
Producer: 20180220Description: 10703-10713 p. digitalISSN:- 1949-2553
- Antineoplastic Agents, Immunological -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bevacizumab -- adverse effects
- Chi-Square Distribution
- Disease Progression
- Disease-Free Survival
- Female
- Humans
- Middle Aged
- Neoplasm Recurrence, Local
- Odds Ratio
- Ovarian Neoplasms -- drug therapy
- Randomized Controlled Trials as Topic
- Risk Factors
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Review; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.